Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Current Value
$0.731 Year Return
Current Value
$0.731 Year Return
Market Cap
$12.01M
P/E Ratio
-0.62
1Y Stock Return
-76.48%
1Y Revenue Growth
-2.33%
Dividend Yield
0.00%
Price to Book
-4.8
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AMED | -27.22% | $2.95B | -3.97% | 0.00% |
LPG | -14.80% | $1.08B | -33.27% | 0.00% |
PRPO | -12.62% | $8.89M | -14.59% | 0.00% |
SPOT | -11.76% | $92.14B | +159.77% | 0.00% |
WRB | -11.61% | $23.68B | +34.33% | 0.68% |
NKE | -10.99% | $111.79B | -30.41% | 1.94% |
DELL | -10.88% | $101.20B | +86.02% | 1.20% |
CBOE | -10.69% | $22.09B | +17.17% | 1.08% |
STNG | -10.33% | $2.81B | -6.67% | 2.97% |
ROL | -9.90% | $24.04B | +24.01% | 1.23% |
NVGS | -9.69% | $1.11B | +6.77% | 1.26% |
ACI | -9.48% | $11.04B | -10.93% | 2.50% |
CMRE | -9.14% | $1.68B | +49.10% | 3.24% |
COCO | -8.97% | $2.08B | +26.18% | 0.00% |
NNE | -8.68% | $965.35M | +631.25% | 0.00% |
LRN | -8.32% | $4.51B | +75.87% | 0.00% |
AGO | -7.92% | $4.69B | +37.23% | 1.01% |
IMNN | -7.65% | $10.05M | -22.14% | 0.00% |
PSTG | -7.40% | $16.90B | +37.90% | 0.00% |
NTES | -7.31% | $55.17B | -24.08% | 2.85% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AHCO | 0.01% | $1.33B | +16.35% | 0.00% |
KOS | -0.02% | $1.89B | -41.00% | 0.00% |
TXMD | 0.02% | $15.34M | -52.16% | 0.00% |
PKE | 0.04% | $300.03M | -1.51% | 3.30% |
ZIMV | -0.04% | $379.21M | +50.33% | 0.00% |
MGNI | 0.05% | $2.33B | +105.08% | 0.00% |
KSPI | -0.05% | $19.73B | +8.16% | 3.55% |
SD | 0.05% | $437.26M | -9.14% | 3.74% |
TME | -0.05% | $8.06B | +36.01% | 1.21% |
MAGN | 0.05% | $676.43M | -1.19% | 0.00% |
TS | 0.06% | $20.84B | +10.28% | 3.63% |
PUBM | -0.06% | $773.82M | +0.25% | 0.00% |
ASX | 0.08% | $21.28B | +14.34% | 3.19% |
INCY | 0.09% | $13.56B | +31.82% | 0.00% |
PAR | 0.09% | $2.80B | +102.47% | 0.00% |
DADA | -0.10% | $361.79M | -64.04% | 0.00% |
NXE | -0.10% | $4.93B | +33.28% | 0.00% |
TSLA | 0.10% | $1.09T | +45.02% | 0.00% |
DHR | -0.10% | $169.77B | +6.21% | 0.45% |
WFC | 0.11% | $249.15B | +74.92% | 2.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DENN | 24.89% | $327.99M | -34.39% | 0.00% |
WHR | 23.69% | $6.13B | +2.08% | 6.24% |
KFRC | 22.48% | $1.12B | -7.67% | 0.64% |
PII | 22.45% | $3.73B | -25.57% | 3.90% |
LPTX | 22.19% | $98.86M | -9.79% | 0.00% |
BC | 21.98% | $5.35B | +3.93% | 2.52% |
ELV | 21.95% | $93.60B | -15.91% | 1.58% |
WDFC | 21.68% | $3.77B | +16.30% | 1.26% |
FUN | 21.31% | $4.54B | -17.47% | 0.00% |
HAS | 21.27% | $8.64B | +35.71% | 4.52% |
JOBY | 21.26% | $5.20B | +18.47% | 0.00% |
SITE | 21.25% | $6.46B | +2.39% | 0.00% |
PNR | 21.21% | $17.52B | +69.08% | 0.87% |
GILT | 21.16% | $296.77M | -16.85% | 0.00% |
ZYME | 21.11% | $950.05M | +64.03% | 0.00% |
HIHO | 21.10% | $8.50M | -1.53% | 6.22% |
NMAI | 20.86% | - | - | 13.07% |
GNTX | 20.82% | $6.80B | -3.80% | 1.60% |
POOL | 20.82% | $13.87B | +2.27% | 1.27% |
WH | 20.79% | $7.50B | +23.40% | 1.54% |
Yahoo
Aspira Womens Health Inc (AWH) reports growth in test volumes and secures a $10 million federal award, despite weather-related setbacks.
Yahoo
Q3 2024 OvaSuiteSM revenue of $2.3 million and volume of 6,001 units Cash utilization for the third quarter was $2.9 million, a decrease of 12% compared to the second quarter of 2024 Full year 2024 cash guidance reconfirmed as $13.0-$14.5 million Conference Call and Webcast scheduled for today at 8:30 am ET AUSTIN, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development
SeekingAlpha
Aspira Women's Health Inc. (NASDAQ:AWH) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsNicole Sandford - Chief Executive...
Yahoo
BioReference team is now able to provide the entire OvaSuite portfolio to healthcare providers in New York and New JerseyAUSTIN, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (NASDAQ: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the expansion of its co-marketing and distribution collaboration with BioReference Health, LLC (“BioReference”), a wholly-owned subsidiary of OPKO
Yahoo
Management to Announce Earnings Results and hold a call at 8:30 am ETAUSTIN, Texas, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three and nine months ended September 30, 2024, on Thursday, November 14, 2024. Management will also host a conference call
Yahoo
Event to feature presentations from Dr. Kevin Elias, Dr. Richard Gersh, Dr. Sandra Milligan, and Dr. Todd Pappas on the Company’s development pipelineAUSTIN, Texas, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, has issued a letter to Company shareholders and announced it will host a virtual Research & Development Day on Tuesday, October 29, 20
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PHO | 22.07% | $2.25B | 0.59% |
IHF | 20.88% | $709.92M | 0.4% |
KBWY | 20.78% | $251.20M | 0.35% |
FIW | 20.42% | $1.87B | 0.53% |
PFLD | 20.08% | $457.12M | 0.46% |
XHB | 19.93% | $2.12B | 0.35% |
XSHD | 19.78% | $54.48M | 0.3% |
VRP | 19.68% | $1.82B | 0.5% |
PFXF | 19.35% | $1.97B | 0.4% |
IFRA | 19.21% | $3.27B | 0.3% |
PINK | 19.18% | $163.05M | 0.5% |
RIET | 19.12% | $89.72M | 0.5% |
VAW | 18.68% | $3.02B | 0.1% |
ITB | 18.47% | $3.32B | 0.39% |
VBR | 18.43% | $32.10B | 0.07% |
IYZ | 18.30% | $492.05M | 0.4% |
SMOT | 18.24% | $374.05M | 0.49% |
IJJ | 18.12% | $8.05B | 0.18% |
SDY | 18.10% | $21.19B | 0.35% |
FMAT | 18.09% | $558.67M | 0.084% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -13.60% | $379.51M | 1.43% |
TBLL | -10.57% | $1.92B | 0.08% |
VIXY | -9.57% | $195.31M | 0.85% |
PREF | -8.32% | $1.01B | 0.55% |
DBO | -6.04% | $218.38M | 0.77% |
DBE | -5.78% | $50.92M | 0.77% |
SMB | -5.76% | $266.92M | 0.07% |
CTA | -5.72% | $359.48M | 0.78% |
ICSH | -5.64% | $5.55B | 0.08% |
GSG | -5.64% | $935.59M | 0.75% |
COMT | -5.56% | $842.63M | 0.48% |
FMHI | -5.54% | $753.14M | 0.7% |
FTGC | -5.48% | $2.21B | 1.02% |
DUSB | -5.45% | $812.64M | 0.15% |
HYMB | -5.40% | $2.81B | 0.35% |
CORN | -5.34% | $61.32M | 0.2% |
BSCP | -5.33% | $4.04B | 0.1% |
AGZ | -5.25% | $709.69M | 0.2% |
PDBC | -5.22% | $4.47B | 0.59% |
SOYB | -4.72% | $27.32M | 0.22% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UTWO | -<0.01% | $442.66M | 0.15% |
HIGH | -0.01% | $301.36M | 0.51% |
LGOV | 0.04% | $606.26M | 0.67% |
FISR | 0.06% | $307.53M | 0.5% |
PYLD | -0.06% | $2.27B | 0.55% |
IBTI | -0.06% | $733.21M | 0.07% |
AGGY | 0.08% | $928.16M | 0.12% |
EWQ | -0.09% | $576.42M | 0.5% |
BINC | 0.11% | $6.37B | 0.4% |
BNDW | -0.13% | $857.97M | 0.05% |
BIV | -0.14% | $20.38B | 0.04% |
FFOG | -0.15% | $120.02M | 0.55% |
EWI | -0.17% | $365.95M | 0.5% |
TDTT | 0.17% | $1.86B | 0.18% |
AVIG | -0.18% | $937.25M | 0.15% |
FLMX | 0.20% | $90.81M | 0.19% |
FEZ | 0.20% | $3.32B | 0.29% |
FLGV | -0.22% | $850.57M | 0.09% |
KRBN | -0.24% | $243.28M | 0.85% |
GOVI | -0.26% | $1.07B | 0.15% |